| | | |
| 07:30 - 09:00 | Free Paper Presentation 9 |
| Meeting
Room 310 | HIV/AIDS |
| | |
| 07:30 - 09:00 | Free Paper Presentation 10 |
| Meeting
Room 311A | Gastro-intestinal Infection and Paediatrics |
| | |
| 07:30 - 09:00 | Free Paper Presentation 11 |
| Meeting Room 311B | Viral Hepatitis and End Stage Liver Disease |
| | | |
| 09:15 - 10:45 | Concurrent Session 13 |
| | Better Patient Care for HIV Infected Patients |
|
CS 13.1 | 09:15 - 09:35 | Treatment algorithm of HIV infected patients in China |
| | | Hongzhou Lu, Shanghai |
| | | |
| CS 13.2 | 09:35 - 09:55 | HAART for HIV in China—much achieved, more
to be done |
| | | Ka-Hing Wong, Hong Kong |
| | | |
| CS 13.3 | 09:55 - 10:15 | IV-1 Drug Resistance monitoring study |
| | | Somnuek Sungkanuparph, Bangkok |
| | | |
| CS 13.4 | 10:15 - 10:35 | Effects of economic and diagnostic resourcing on patient treatment outcomes |
| | | Fujie Zhang, Beijing |
| | | |
| | 10:35 - 10:45 | Discussion |
| | | |
| 09:15 - 10:45 | Concurrent Session 14 |
| Meeting Room 311A | Viral Hepatitis and Liver Cancer |
| CS 14.1 | 09:15 - 09:35 | The risk of hepatocellular
carcinoma in HCV-related chronic hepatitis |
| | Masao Omata, Tokyo |
| | |
| CS 14.2 | 09:35 - 09:55 | Risk assessment of HBV-related HCC development using
liver stiffness measurement |
| | Seung Up Kim, Seoul |
| | |
| CS 14.3 | 09:55 - 10:15 | The potential of genetically modified T cells
to prevent HBV related HCC |
| | Adam
J. Gehring, Singapore |
| | |
| CS 14.4 | 10:15 - 10:35 | Translational study
of HBV infection related with hepatocellular carcinomas |
| | Fengmin Lu, Beijing |
| | |
| 10:35 - 10:45 | Discussion |
| | | |
| 10:45 - 11:15 | Poster Session / Coffee Break |
| | | |
| 11:15 - 12:45 | Concurrent Session 15 |
| Meeting Room 310 | Detection and Clinical Significance of Virla Infection |
| CS 15.1 | 11:15
- 11:35 | CMV in transplant recipients |
| | Ban Hock Tan, Singapore |
| | |
| CS 15.2 | 11:35 - 11:55 | Drug design and development against EV71 and
other enteroviuses |
| | Tianwei
Lin, Xiamen |
| | |
| CS 15.3 | 11:55 - 12:15 | More and more coronaviruses
after the SARS epidemic: human coronavirus HKU1 and other coronaviruses |
| | Patrick C.Y. Woo, Hong Kong |
| | |
| CS 15.4 | 12:15 - 12:35 | Herpesvirus |
| | TBC |
| | |
| 12:35 - 12:45 | Discussion |
| | | |
| 11:15 - 12:45 | Concurrent
Session 16 |
| Meeting Room 311A | End Stage Liver
Disease and Complications |
| CS 16.1 | 11:15
- 11:35 | Management of the complications of liver cirrhosis |
| | Hong You, Beijing |
| | |
| CS 16.2 | 11:35 - 11:55 | Improving survival in patients with decompensated
cirrhosis |
| | Deepak
N. Amarapurkar, Mumbai |
| | |
| CS 16.3 | 11:55 - 12:15 | New concept in nomenclature,
classification and diagnosis of liver failure |
| | Yuming Wang, Chongqing |
| | |
| CS 16.4 | 12:15 - 12:35 | Treatment strategy developments of hepatitis
B with liver failure |
| | Zhiliang
Gao, Guangzhou |
| | |
| 12:35 - 12:45 | Discussion |